These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10862783)

  • 21. Humoral immunity and atherosclerosis.
    Virella G; Lopes-Virella MF
    Nat Med; 2003 Mar; 9(3):243-4; author reply 244-5. PubMed ID: 12612552
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    Zhou X; Paulsson G; Stemme S; Hansson GK
    J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
    Gonçalves I; Cherfan P; Söderberg I; Nordin Fredrikson G; Jonasson L
    Autoimmunity; 2009 Mar; 42(3):203-8. PubMed ID: 19301201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein autoantibodies: measurement and significance.
    Virella G; Lopes-Virella MF
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):499-505. PubMed ID: 12853376
    [No Abstract]   [Full Text] [Related]  

  • 25. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidised LDL and progression of atherosclerosis.
    Strahilevitz M
    Lancet; 1992 Jul; 340(8813):235; author reply 236. PubMed ID: 1353149
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.
    Wu JT; Wu LL
    Clin Lab Med; 1997 Sep; 17(3):595-604. PubMed ID: 9316776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atherosclerosis and the system of immunity].
    Nagornev VA; Pigarevskiĭ PV; Ogurtsov RP; Denisenko AD
    Arkh Patol; 1985; 47(4):15-21. PubMed ID: 3873930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunology. The push-me pull-you of T cell activation.
    Carson MJ; Lo D
    Science; 2001 Jul; 293(5530):618-9. PubMed ID: 11474091
    [No Abstract]   [Full Text] [Related]  

  • 30. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
    Freire de Carvalho J; Sherer Y; Shoenfeld Y
    Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
    van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?
    Shoenfeld Y; Wu R; Dearing LD; Matsuura E
    Circulation; 2004 Oct; 110(17):2552-8. PubMed ID: 15505108
    [No Abstract]   [Full Text] [Related]  

  • 34. [Isolation and identification of autoimmune lipoprotein-antibody complex from blood serum of rabbits with experimental atherosclerosis].
    Klimov AN; Petrova-Maslakova LG; Nagornev VA; Magracheva YY
    Vopr Med Khim; 1975; 21(5):526-31. PubMed ID: 175569
    [No Abstract]   [Full Text] [Related]  

  • 35. Atherosclerosis, autoimmunity, and systemic lupus erythematosus.
    Thiagarajan P
    Circulation; 2001 Oct; 104(16):1876-7. PubMed ID: 11602485
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular disease.
    de Geest B; Collen D
    Eur Heart J; 2001 Sep; 22(17):1517-8. PubMed ID: 11492979
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.
    Schenkein HA; Berry CR; Purkall D; Burmeister JA; Brooks CN; Tew JG
    Infect Immun; 2001 Nov; 69(11):6612-7. PubMed ID: 11598029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
    Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL
    J Clin Invest; 2004 Aug; 114(3):427-37. PubMed ID: 15286809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of autoimmune lipoprotein--antibody complex in human plasma and aortic wall].
    Klimov AN; Denisenko AD; Zubzhitskiĭ IuN; Gerchikova EA
    Vopr Med Khim; 1978; 24(4):539-43. PubMed ID: 210589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.